ESR1 and breast carcinoma: Of particular relevance, the S protein at the concentration of 10 ng/mL (about 0.13 nM) increased the proliferation of the breast cancer cell line MCF-7 through the activation of ER, as suggested by the ability of raloxifene, a potent and selective ER modulator, to block this effect [34].